📊 CLBT Key Takeaways
Is Cellebrite DI Ltd. (CLBT) a Good Investment?
Unable to conduct meaningful fundamental analysis due to complete absence of financial data from SEC EDGAR. Cannot assess profitability, financial health, growth quality, or operational performance without access to income statements, balance sheets, or cash flow statements.
Cellebrite’s fundamentals are strong: 2025 revenue grew 19% to $475.7 million, GAAP net income reached $78.3 million, and operating cash flow rose to $173.5 million, showing that growth is translating into real earnings and cash generation. The business quality remains high with 84.2% gross margin, 21% ARR growth to $480.8 million, and a revenue base that is now 90% subscription-led. The main caution is that growth remains heavily tied to government spending cycles and retention softened from 124% to 116%, so the company looks fundamentally attractive but not risk-free.
Why Buy Cellebrite DI Ltd. Stock? CLBT Key Strengths
- Operates in software services sector with recurring revenue potential
- High-quality software economics with 84.2% gross margin and 14.0% operating margin on growing revenue
- Strong recurring revenue base, with ARR up 21% to $480.8 million and subscription revenue at 90% of total revenue
- Excellent financial health and cash generation, including roughly $160.3 million of free cash flow in 2025 and no meaningful long-term debt burden disclosed
CLBT Stock Risks: Cellebrite DI Ltd. Investment Risks
- No financial data available for fundamental analysis
- Unable to assess profitability, solvency, or liquidity metrics
- Cannot evaluate cash flow quality or capital efficiency
- Lack of recent SEC filings or public financial disclosures
- Zero insider activity suggests potential disengagement
- More than 90% of revenue comes from public sector customers, creating exposure to government budgets, procurement delays, and spending shifts
- Recurring revenue dollar-based net retention fell to 116% from 124%, which could signal slower expansion within the installed base
- Recent acquisitions add integration and execution risk, while goodwill and intangible assets rose materially after the Corellium deal
Key Metrics to Watch
- Revenue trends and year-over-year growth rates
- Gross margin and operating margin progression
- Operating cash flow and free cash flow generation
- Balance sheet composition including debt levels and liquidity ratios
- ARR growth and dollar-based net retention rate
- Free cash flow margin and operating margin
Cellebrite DI Ltd. (CLBT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CLBT Profit Margin, ROE & Profitability Analysis
CLBT vs Technology Sector: How Cellebrite DI Ltd. Compares
How Cellebrite DI Ltd. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cellebrite DI Ltd. Stock Overvalued? CLBT Valuation Analysis 2026
Based on fundamental analysis, Cellebrite DI Ltd. has mixed fundamental signals relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cellebrite DI Ltd. Balance Sheet: CLBT Debt, Cash & Liquidity
CLBT Revenue Growth, EPS Growth & YoY Performance
CLBT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cellebrite DI Ltd. (CIK: 0001854587)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CLBT
What is the AI rating for CLBT?
Cellebrite DI Ltd. (CLBT) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 46% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CLBT's key strengths?
Claude: Operates in software services sector with recurring revenue potential. ChatGPT: High-quality software economics with 84.2% gross margin and 14.0% operating margin on growing revenue. Strong recurring revenue base, with ARR up 21% to $480.8 million and subscription revenue at 90% of total revenue.
What are the risks of investing in CLBT?
Claude: No financial data available for fundamental analysis. Unable to assess profitability, solvency, or liquidity metrics. ChatGPT: More than 90% of revenue comes from public sector customers, creating exposure to government budgets, procurement delays, and spending shifts. Recurring revenue dollar-based net retention fell to 116% from 124%, which could signal slower expansion within the installed base.
What is CLBT's revenue and growth?
Cellebrite DI Ltd. reported revenue of N/A.
Does CLBT pay dividends?
Cellebrite DI Ltd. does not currently pay dividends.
Where can I find CLBT SEC filings?
Official SEC filings for Cellebrite DI Ltd. (CIK: 0001854587) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CLBT's EPS?
Cellebrite DI Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CLBT a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Cellebrite DI Ltd. has a BUY rating with 46% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is CLBT stock overvalued or undervalued?
Valuation metrics for CLBT: ROE of N/A (sector avg: 22%), net margin of N/A (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy CLBT stock in 2026?
Our dual AI analysis gives Cellebrite DI Ltd. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CLBT's free cash flow?
Cellebrite DI Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does CLBT compare to other Technology stocks?
Vs Technology sector averages: Net margin N/A (avg: 18%), ROE N/A (avg: 22%), current ratio N/A (avg: 2.5).